Unlock instant, AI-driven research and patent intelligence for your innovation.
Application of pharmaceutical composition in preparation of medicine for preventing and/or treating thin endometrium or infertility
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
An endometrial and composition technology, which is applied in the directions of drug combination, drug delivery, plant/algae/fungus/moss components, etc., can solve the problems of complex treatment methods and high cost, and achieve excellent therapeutic effects.
Active Publication Date: 2021-09-03
陆华
View PDF2 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, this treatment method needs to give compound Xuanju Capsules and estrogen to the patient at the same time, the cost is high, and the treatment method is relatively complicated.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0026] Embodiment 1, the preparation of pharmaceutical composition of the present invention
[0028] Preparation method: take the above-mentioned herbal flavors, add water to decoct, decoct twice in total, add water 6 times (v / w, ml / g) of the raw medicinal materials each time, combine the two decoction liquids, concentrate to a thick extract (The relative density is about 1.2), and the dregs are dried and finely powdered, then mixed with the extract, and spray-dried into granules.
Embodiment 2
[0029] Embodiment 2, the preparation of pharmaceutical composition of the present invention
[0031] Preparation method: take the above-mentioned herbs, add water to decoct, decoct twice in total, add water 8 times (v / w, ml / g) the amount of raw medicinal materials each time, combine two decoctions, concentrate to a thick extract (relative density is about 1.35), the dregs are dried and finely powdered, then mixed with the extract, spray-dried into granules.
Embodiment 3
[0032] Embodiment 3, the preparation of pharmaceutical composition of the present invention
[0034] Preparation method: take the above-mentioned herbs, add water to decoct, decoct 2 times in total, add water 7 times (v / w, ml / g) the amount of raw medicinal materials each time, combine the two decoctions, concentrate to a thick extract (The relative density is about 1.3), and the dregs are dried and finely powdered, then mixed with the extract, and spray-dried into granules.
[0035] The beneficial effect of the pharmaceutical composition of the present invention is demonstrated by the following experimental examples.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Property
Measurement
Unit
Thickness
aaaaa
aaaaa
Login to View More
Abstract
The invention provides application of a pharmaceutical composition in preparation of a medicine for preventing and / or treating thin endometrium or infertility. The pharmaceutical composition is a preparation prepared from the following raw material medicines in parts by weight of 7-13 parts of herba epimedii, 7-13 parts of rhizoma drynariae and 7-13 parts of herba cistanche. Experiments prove that after the pharmaceutical composition provided by the invention is taken, the endometrial receptivity of a thin endometrial (kidney-yang deficiency syndrome) patient is remarkably improved, the endometrial thickness, the female progestational hormone level in the middle stage of corpus luteum and the endometrial blood supply of the patient are remarkably improved, and the total effective rate of treatment is up to 87.88%. The pharmaceutical composition provided by the invention is precise and appropriate in compatibility, and has a wide prospect in preparation of medicines for preventing and / or treating kidney-yang deficiency type thin endometrium and thin endometrial infertility.
Description
technical field [0001] The invention belongs to the field of pharmacy, and in particular relates to the use of a pharmaceutical composition in the preparation of medicines for preventing and / or treating thin endometrium or infertility. Background technique [0002] In 1995, the World Health Organization (WHO) found that the number of infertile couples in the world had reached 60-80 million. Therefore, WHO regards infertility as the world's third largest impact on human physical and mental health after cardiovascular diseases and tumor diseases. disease. At present, the incidence of infertility in the world is increasing year by year. According to incomplete statistics, the incidence of infertility in my country is 7-10% in recent years. Although the assisted reproductive technology (ART) of modern medicine has brought hope to the majority of infertility patients, studies have shown that about 2.4% of patients were forced to cancel or terminate ART due to the thin endometriu...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
